NARI - NARI CLASS ACTION: Contact Robbins LLP for Information About the Class Action Against Inari Medical Inc. | Benzinga
SAN DIEGO, June 24, 2024 (GLOBE NEWSWIRE) --
Robbins LLP reminds investors that a shareholder filed a class action on behalf of all purchasers of Inari Medical, Inc. (NASDAQ:NARI) common stock between February 24, 2022 and February 28, 2024. Inari is a medical device company that specializes in developing, manufacturing and commercializing catheter-based technologies for treating venous thromboembolism ("VTE"), a condition that occurs when a blood clot forms in a vein, usually in the lower leg, thigh, or pelvis.
For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.
The Allegations: Robbins LLP is Investigating Allegations that Inari Medical, Inc. (NARI) Failed to Disclose that Bribes and Kickbacks Would Negatively Impact its Financial Results
According to the complaint, on February 29, 2024, Inari disclosed it received a civil investigative demand by ...